BioCentury
ARTICLE | Clinical News

RG7314: Phase I started

February 4, 2013 8:00 AM UTC

Roche said in its 4Q12 earnings that it began a Phase I trial to evaluate multiple doses of RG7314 in combination with a single dose of risperidone in up to 24 healthy volunteers. ...